Top

Archives of Osteoporosis

Published in:

01-12-2022 | Osteoporosis | Original Article

Bibliometric analysis of the top 100 most-cited articles on the treatment of osteoporosis

Authors: Mustafa Hüseyin Temel, İbrahim Halil Erdem, Ayhan Kul, Fatih Bağcıer

Published in: Archives of Osteoporosis | Issue 1/2022

Abstract

Purpose

To perform a bibliometric analysis of the top 100 (T100) most-cited articles on the treatment of osteoporosis published between 1980 and 2021 to reveal major developments and trends in the field and to contribute to the methodologies and hypotheses of future studies.

Methods

On 15.12.2021, a search was conducted on the Web of Science database using the keyword “osteoporosis treatment” to screen articles published between 1980 and 2021. The title of the article, year of publication, total number and names of the authors, total number of citations and citation index, name and Q index of the journals, H-index, impact factor, country of authors, types of articles, and sources of funding were recorded.

Results

The most-cited article was “Osteoporosis Prevention, Diagnosis, And Therapy.” The article with the highest citation index was “Clinician’s Guide to Prevention and Treatment of Osteoporosis.. The majority of the articles were randomized controlled clinical trials. The journal with the highest number of articles included in the T100 was The New England Journal of Medicine, with 19 articles. The USA had the highest number of articles. There was a strong correlation between the number of citations and citation index of articles (p < 0.001).

Conclusions

This study, which examined the T100 most-cited articles on the treatment of osteoporosis, found that the articles primarily focused on the prevention, diagnosis, and follow-up of osteoporosis; search for antiresorptive and anabolic pharmacological agents; investigation of the efficacy and reliability of these agents on specific subpopulations; and surgical treatment options.

Available only for authorised users

Suzan V, Bektan Kanat B, Yavuzer H, Doventas A (2021) Themes and trends for osteoporosis: the bibliometric and altmetric approach. Arch Osteoporos 16:122. https://doi.org/10.1007/s11657-021-00983-wCrossRefPubMed

Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM (2018) A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 14:2029–2049. https://doi.org/10.2147/TCRM.S138000CrossRefPubMedPubMedCentral

Tella SH, Gallagher JC (2014) Prevention and treatment of postmenopausal osteoporosis. J Steroid Biochem Mol Biol 142:155–170. https://doi.org/10.1016/j.jsbmb.2013.09.008CrossRefPubMed

Sözen T, Özışık L, Başaran NÇ (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46–56. https://doi.org/10.5152/eurjrheum.2016.048CrossRefPubMed

Ellegaard O, Wallin JA (2015) The bibliometric analysis of scholarly production: how great is the impact? Scientometrics 105:1809–1831. https://doi.org/10.1007/s11192-015-1645-zCrossRefPubMedPubMedCentral

Ho Y-S (2012) Top-cited articles in chemical engineering in science citation index expanded: a bibliometric analysis. Chin J Chem Eng 20:478–488. https://doi.org/10.1016/S1004-9541(11)60209-7CrossRef

Publications impact indexes. In: Mondragon Unibertsitatea. https://www.mondragon.edu/en/web/biblioteka/publications-impact-indexes. Accessed 25 Jun 2022

Qiu Y, Yang W, Wang Q et al (2018) Osteoporosis in postmenopausal women in this decade: a bibliometric assessment of current research and future hotspots. Arch Osteoporos 13:121. https://doi.org/10.1007/s11657-018-0534-5CrossRefPubMed

Gao Q, Zhang C, Wang J et al (2020) The top 100 highly cited articles on osteoporosis from 1990 to 2019: a bibliometric and visualized analysis. Arch Osteoporos 15, 144. https://doi.org/10.1007/s11657-020-0705-z

10.

Osteoporosis is a neglected health priority in Arab World: a comparative bibliometric analysis. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141069/. Accessed 31 Jan 2022

11.

Wu H, Sun Z, Tong L et al (2021) Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention. Arch Osteoporos 16:154. https://doi.org/10.1007/s11657-021-01016-2CrossRefPubMed

12.

Brüggmann D, Mäule L-S, Klingelhöfer D et al (2016) World-wide architecture of osteoporosis research: density-equalizing mapping studies and gender analysis. Climacteric J Int Menopause Soc 19:463–470. https://doi.org/10.1080/13697137.2016.1200548CrossRef

13.

Zhou S, Tao Z, Zhu Y, Tao L (2019) Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis. PeerJ 7:e8145. https://doi.org/10.7717/peerj.8145CrossRefPubMedPubMedCentral

14.

Wu H, Cheng K, Guo Q et al (2021) Mapping knowledge structure and themes trends of osteoporosis in rheumatoid arthritis: a bibliometric analysis. Front Med 8:787228. https://doi.org/10.3389/fmed.2021.787228CrossRef

15.

Yun L, Wang L, Pan Y et al (2021) Current status and development trend of miRNAs in osteoporosis-related research: a bibliometric analysis. Folia Histochem Cytobiol 59:203–211. https://doi.org/10.5603/FHC.a2021.0024CrossRefPubMed

16.

Shahid I, Motiani V, Siddiqi TJ et al (2020) Characteristics of highly cited articles in heart failure: a bibliometric analysis. Future Cardiol 16:189–197. https://doi.org/10.2217/fca-2019-0016CrossRefPubMed

17.

Held M, Castelein S, Bruins M-F et al (2018) Most influential literature in spinal tuberculosis: a global disease without global evidence. Glob Spine J 8:84–94. https://doi.org/10.1177/2192568217707182CrossRef

18.

Yin X, Cheng F, Wang X et al (2019) Top 100 cited articles on rheumatoid arthritis: a bibliometric analysis. Medicine (Baltimore) 98:e14523. https://doi.org/10.1097/MD.0000000000014523CrossRefPubMed

19.

Neer RM, Arnaud CD, Zanchetta JR et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441. https://doi.org/10.1056/NEJM200105103441904CrossRefPubMed

20.

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785–795. https://doi.org/10.1001/jama.285.6.785CrossRef

21.

Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 25:2359–2381. https://doi.org/10.1007/s00198-014-2794-CrossRef

22.

Kanis JA, Cooper C, Rizzoli R et al (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 30:3–44. https://doi.org/10.1007/s00198-018-4704-5CrossRef

23.

Bone and joint health national action week - October 12–18, 2022 - National Today. https://nationaltoday.com/bone-and-joint-health-national-action-week/. Accessed 31 Dec 2021

24.

Harris ST, Watts NB, Jackson RD et al (1993) Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med 95:557–567. https://doi.org/10.1016/0002-9343(93)90350-xCrossRefPubMed

25.

Black DM, Bilezikian JP, Ensrud KE et al (2005) One year of alendronate after one year of parathyroid hormone (1–84) for osteoporosis. N Engl J Med 353:555–565. https://doi.org/10.1056/NEJMoa050336CrossRefPubMed

26.

Black DM, Thompson DE, Bauer DC et al (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85:4118–4124. https://doi.org/10.1210/jcem.85.11.6953CrossRefPubMed

27.

Black DM, Schwartz AV, Ensrud KE et al (2006) Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 296:2927–2938. https://doi.org/10.1001/jama.296.24.2927CrossRefPubMed

28.

Lane NE, Sanchez S, Modin GW et al (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:1627–1633. https://doi.org/10.1172/JCI3914CrossRefPubMedPubMedCentral

29.

Brookes BC (1969) Bradford’s law and the bibliography of science. Nature 224:953–956. https://doi.org/10.1038/224953a0CrossRefPubMed

30.

Bağcıer F (2021) Top 100 cited articles on fibromyalgia syndrome: a bibliometric and altmetric analyses study. Ağrı - J Turk Soc Algol. https://doi.org/10.14744/agri.2021.53189

31.

Fisher JE, Rogers MJ, Halasy JM et al (1999) Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci 96:133–138. https://doi.org/10.1073/pnas.96.1.133CrossRefPubMedPubMedCentral

32.

Orwoll E, Ettinger M, Weiss S et al (2000) Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604–610. https://doi.org/10.1056/NEJM200008313430902CrossRefPubMed

33.

Schnitzer T, Bone HG, Crepaldi G et al (2000) Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging Milan Italy 12:1–12PubMed

34.

Tonino RP, Meunier PJ, Emkey R et al (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab 85:3109–3115. https://doi.org/10.1210/jcem.85.9.6777CrossRefPubMed

35.

Kurland ES, Cosman F, McMahon DJ et al (2000) Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers. J Clin Endocrinol Metab 85:3069–3076. https://doi.org/10.1210/jcem.85.9.6818CrossRefPubMed

36.

Dempster DW, Cosman F, Kurland ES et al (2001) Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res Off J Am Soc Bone Miner Res 16:1846–1853. https://doi.org/10.1359/jbmr.2001.16.10.1846CrossRef

37.

Reid IR (1998) Glucocorticoid-induced osteoporosis: assessment and treatment. J Clin Densitom 1:65–73. https://doi.org/10.1385/JCD:1:1:65CrossRefPubMed

38.

Manolagas SC, Weinstein RS (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res Off J Am Soc Bone Miner Res 14:1061–1066. https://doi.org/10.1359/jbmr.1999.14.7.1061CrossRef

39.

Garfin SR, Yuan HA, Reiley MA (2001) New technologies in spine: kyphoplasty and vertebroplasty for the treatment of painful osteoporotic compression fractures. Spine 26:1511–1515. https://doi.org/10.1097/00007632-200107150-00002CrossRefPubMed

40.

Cortet B, Cotten A, Boutry N et al (1999) Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study. J Rheumatol 26:2222–2228PubMed

41.

Heini PF, Wälchli B, Berlemann U (2000) Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early results. A prospective study for the treatment of osteoporotic compression fractures. Eur Spine J Off Publ Eur Spine Soc Eur Spinal Deform Soc Eur Sect Cerv Spine Res Soc 9:445–450. https://doi.org/10.1007/s005860000182CrossRef

42.

Ensrud KE, Crandall CJ (2017) Osteoporosis. Ann Intern Med 167:ITC17–ITC32. https://doi.org/10.7326/AITC201708010

43.

Rashki Kemmak A, Rezapour A, Jahangiri R et al (2020) Economic burden of osteoporosis in the world: a systematic review. Med J Islam Repub Iran 34:154. https://doi.org/10.34171/mjiri.34.154

44.

A bibliometric analysis of fragility fractures: top 50 - PubMed. https://pubmed.ncbi.nlm.nih.gov/34205638/. Accessed 11 Jan 2022

45.

Ballane G, Cauley JA, Luckey MM, Fuleihan GE-H (2014) Secular trends in hip fractures worldwide: opposing trends east versus west. J Bone Miner Res 29:1745–1755. https://doi.org/10.1002/jbmr.2218CrossRefPubMed

Title: Bibliometric analysis of the top 100 most-cited articles on the treatment of osteoporosis
Authors: Mustafa Hüseyin Temel
İbrahim Halil Erdem
Ayhan Kul
Fatih Bağcıer
Publication date: 01-12-2022
Publisher: Springer London
Keywords: Osteoporosis
Osteoporosis
Published in: Archives of Osteoporosis / Issue 1/2022
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-022-01141-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Bibliometric analysis of the top 100 most-cited articles on the treatment of osteoporosis

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Does hip structural analysis confer additional benefit to routine BMD assessment in postmenopausal women with hip fracture? A study from a tertiary center in southern India

Trends in osteoporotic fracture and related in-hospital complications during the COVID-19 pandemic in Alberta, Canada

Prevalent vertebral fractures among urban-dwelling Chinese postmenopausal women: a population-based, randomized-sampling, cross-sectional study

Effectiveness of an osteoporosis prevention educational program in Tunisian premenopausal women working in sedentary occupations: a quasi-experimental study

Patient-specific factors affecting survival following hip fractures—a 14-year follow-up study in Finland

Incidence of Hip Fractures during the COVID-19 Pandemic in Brazil